1 year return (CAGR)
10.35%
A2A S.p.A Exchange (MI, EUR)
A2A.MI
-
-0.03 (-1.28%)
UtilitiesUtilities - Diversified
Loading...
3 year return (CAGR)
21.17%
5 year return (CAGR)
11.56%
10 year return (CAGR)
8.31%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
7.70B
Price/Sales
0.37
Ent value
-
Price/Book
1.36
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
6.35
PEG
-
Forward P/E
11.30
EPS growth
17.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 2.48 |
| Daily high | 2.48 |
| Daily low | 2.42 |
| Daily Volume | 22.2M |
| 1y analyst estimate | 2.61 |
| Beta | 0.94 |
| EPS (TTM) | 0.39 |
| Dividend per share | 0.00 |
| Ex-div date | 20 May 2025 |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| A2A.MI | S&P500 | |
| Current price drop from All-time high | -70.16% | -1.98% |
| Highest price drop | -96.50% | -56.47% |
| Date of highest drop | 24 Jul 2012 | 9 Mar 2009 |
| Avg drop from high | -76.21% | -10.67% |
| Avg time to new high | 117 days | 12 days |
| Max time to new high | 6580 days | 1805 days |
News
Leadership change at CTS Eventim KGaA CTS Eventim KGaA (XTRA:EVD) is in focus after Chief Financial Officer Dr. William Willms left his role on 30 September 2026, with Senior Vice President Finance Dr...
October 5, 2026
Investing.com -- Goldman Sachs expects strong quarterly results from several European utility companies, with RWE, Naturgy, Enel, and EDP positioned to potentially exceed their full-year guidance. The...
October 5, 2026
MONTHLY DECLARATION OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES (ARTICLE L233-8II THE COMMERCIAL CODE and 223-16 OF THE GENERAL REGULATIONS OF THE FINANCIAL MARKETS AUTHORITY (AMF)) Charenton-le-P...
October 5, 2026
PARIS, October 05, 2026--Groupe Pierre & Vacances-Center Parcs : nombre d'actions et de droits de vote au 30 septembre 2026
October 5, 2026
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly medicin...
October 5, 2026
Bonduelle has booked an impairment charge on goodwill in its North American business, contributing to a loss from continuing operations.
October 5, 2026
Schouw & Co. share buy-back programme, week 40 2026 On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the progr...
October 5, 2026
Investing.com -- J.P. Morgan on Monday put Givaudan on Positive Catalyst Watch ahead of its Oct. 13 third-quarter results, expecting organic sales growth of 6.7%, above consensus of about 5%.
October 5, 2026
SALEM, N.H., October 05, 2026--Analogic Corporation ("Analogic"), Altaris, LLC, and Leidos, Inc. (NYSE: LDOS) today announced the completion of the previously announced transaction combining Analogic ...
October 5, 2026
Investing.com -- Barclays on Monday upgraded Givaudan to “overweight” from “equal weight” and raised its price target by 12% to CHF 3,850, citing stronger growth prospects for its Taste & Wellbeing bu...
October 5, 2026